Volume 57, Issue 4, Pages (April 2000)

Slides:



Advertisements
Similar presentations
A model of the interaction of a steroid, S (eg, cortisol), and its receptor, R, and the subsequent events in a target cell. The steroid is present in the.
Advertisements

John W. Bloom, MD  Journal of Allergy and Clinical Immunology 
Dyslipidemia in chronic kidney disease: Causes and consequences
New Vitamin D analogs and changing therapeutic paradigms
Heat shock protein 90 as a molecular target for cancer therapeutics
Molecular Chaperones: Resurrection or destruction?
Molecular mechanisms of diabetic renal hypertrophy
Cleave to Leave Molecular Cell
Volume 58, Issue 1, Pages (July 2000)
Volume 85, Issue 3, Pages (March 2014)
Volume 71, Issue 8, Pages (April 2007)
Volume 73, Issue 9, Pages (May 2008)
Cystic Fibrosis as a Disease of Misprocessing of the Cystic Fibrosis Transmembrane Conductance Regulator Glycoprotein  John R. Riordan  The American Journal.
Protein Turnover: A CHIP Programmed for Proteolysis
New vitamin D analogs Kidney International
Volume 71, Issue 11, Pages (June 2007)
Cyclooxygenase-2 in the kidney: good, BAD, or both?
Volume 80, Issue 8, Pages (October 2011)
Volume 79, Issue 11, Pages (June 2011)
Volume 73, Issue 12, Pages (June 2008)
Volume 49, Issue 1, Pages 1-3 (January 2013)
Structure, not just function
Low oxygen stimulates the immune system
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Kidney failure and the gut: p-cresol and the dangers from within
Alternate-day dialysis may be needed for hemodialysis patients
AGEs in foods: Do they play a role in uremia?
Volume 116, Issue 4, Pages (February 2004)
Dynamic Remodeling of Transcription Complexes by Molecular Chaperones
The Expanding Cosmos of Nuclear Receptor Coactivators
Volume 56, Issue 4, Pages (October 1999)
Nephrology Crossword: Glomerulonephritis
In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)
Rajnish Mehrotra, Joel D. Kopple, Marsha Wolfson  Kidney International 
Volume 57, Issue 4, Pages (April 2000)
Mineralocorticoid selectivity: Molecular and cellular aspects
Fibroblast growth factor 23: the making of a hormone
Volume 73, Issue 9, Pages (May 2008)
It's not over till the last glomerulus forms
Volume 82, Issue 9, Pages (November 2012)
Torsten Klengel, Elisabeth B. Binder  Neuron 
Organ transplantation goes to the movies
Stephen O'Neill, Jeremy Hughes  Kidney International 
Genetics of hypercalciuric stone forming diseases
Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling  Jens Demand, Simon Alberti, Cam Patterson,
Nuclear factors, hs1,2 enhancer and IgA nephropathy
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Pablo A. Ureña Torres, Marc De Broe  Kidney International 
Volume 80, Issue 10, Pages (November 2011)
Volume 82, Issue 6, Pages (September 2012)
Volume 83, Issue 4, Pages (April 2013)
Takamune Takahashi, Uyen Huynh-Do, Thomas O. Daniel 
Volume 80, Issue 10, Pages (November 2011)
Volume 73, Issue 8, Pages (April 2008)
Is it the low-protein diet or simply the salt restriction?
Volume 57, Issue 3, Pages (March 2000)
Charles A. Herzog  Kidney International 
Is complement a target for therapy in renal disease?
Volume 70, Issue 3, Pages (August 2006)
Volume 71, Issue 9, Pages (May 2007)
Volume 75, Issue 7, Pages (April 2009)
T cells and T-cell receptors in acute renal failure
The international realities of live donor kidney transplantation
Tumor necrosis factor-α in cisplatin nephrotoxicity: A homebred foe?
Volume 74, Issue 10, Pages (November 2008)
Volume 75, Issue 8, Pages (April 2009)
Torsten Klengel, Elisabeth B. Binder  Neuron 
Update on glucocorticoid action and resistance
Cellular Evolution: What's in a Mitochondrion?
Presentation transcript:

Volume 57, Issue 4, Pages 1241-1249 (April 2000) Role of molecular chaperones in subnuclear trafficking of glucocorticoid receptors  Dr Donald B. DeFranco  Kidney International  Volume 57, Issue 4, Pages 1241-1249 (April 2000) DOI: 10.1046/j.1523-1755.2000.00957.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Subnuclear trafficking of glucocorticoid receptor (GR). GR that is bound to hormone (H) associates with high-affinity binding sites on chromatin or with the nuclear matrix. Chromatin and the nuclear matrix are depicted as separate and distinct compartments for simplicity alone and may, in fact, be physically linked. Although it is unclear whether hormone must dissociate from receptors for their release from the nuclear matrix, adenosine 5′-triphosphate (ATP) is required for receptor release from, but not binding to, the nuclear matrix. The chaperone activity of heat shock protein 90 (hsp90) may facilitate the release of unliganded receptor from chromatin. At least three alternative processing fates are available for unliganded GR: degradation, nuclear export, and recycling. It appears that unliganded GRs are fully competent to rebind hormone and therefore likely to be assembled into a heteromeric complex. Kidney International 2000 57, 1241-1249DOI: (10.1046/j.1523-1755.2000.00957.x) Copyright © 2000 International Society of Nephrology Terms and Conditions